ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ALCJ Crossject

2.03
-0.045 (-2.17%)
Last Updated: 06:30:57
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Crossject ALCJ Euronext Ordinary Share
  Price Change Change Percent Stock Price Last Traded
-0.045 -2.17% 2.03 06:30:57
Open Price Low Price High Price Close Price Prev Close
2.07 1.974 2.07 2.075
more quote information »

Recent News

Date Time Source Heading
4/17/20248:00IHNWFeaturedGlucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring
4/10/202410:30GLOBECrossject : Information relative au nombre total de droits..
4/02/202412:35GLOBECrossject trading on Euronext to resume as usual on..
4/02/202404:30GLOBECrossject advances in its U.S. Strategy and reports..
3/08/202401:30GLOBECrossject gender equality score reaches 96/100 in 2024
2/27/202402:30GLOBECrossject obtient un financement jusqu’à 12 millions d’euros..
2/06/202411:30GLOBECrossject publie une mise à jour stratégique de ses..
2/01/202412:15GLOBECrossject organisera un webcast le 6 février à 17h30 pour..
1/16/202411:15GLOBECrossject : Information relative au nombre total de droits..
1/09/202410:21GLOBECrossject to present at Biotech Showcase on January 9 at..
1/04/202412:00GLOBECrossject engage Syneos Health pour le lancement commercial..
12/22/202301:30GLOBECrossject signs ZEPIZURE® commercialization agreement for..
12/20/202310:40GLOBECrossject : Information relative au nombre total de droits..
11/28/202301:30GLOBECrossject annonce l’initiation de la couverture de son titre..
11/14/202311:35GLOBECrossject : Information relative au nombre total de droits..
10/05/202302:45GLOBECrossject : Information relative au nombre total de droits..
9/26/202311:35GLOBECrossject reports financial results and business highlights..
9/11/202311:35GLOBECrossject : Information relative au nombre total de droits..
9/11/202301:30GLOBECrossject annonce une nouvelle nette amélioration de sa..
9/05/202307:00GLOBECrossject reports successful completion of European and U.S...
9/05/202301:30GLOBECrossject reports successful completion of European and U.S...
8/08/202311:49GLOBECrossject : Information relative au nombre total de droits..
7/24/202312:00GLOBECrossject : Information relative au nombre total de droits..
7/20/202310:55GLOBECrossject signs new licensing agreement on ZENEO® Midazolam..
7/20/202301:30GLOBECrossject signe un nouvel accord de licence pour le..
7/10/202312:00GLOBECROSSJECT - Information relative au nombre total de droits..
6/30/202302:30GLOBECrossject répond aux questions posées par les actionnaires..
6/12/202312:00GLOBECrossject à l'écoute de ses actionnaires individuels et des..
6/05/202312:00GLOBECROSSJECT - Information relative au nombre total de droits..
6/01/202312:30GLOBECrossject - Appointment of Daniel Teper to the Crossject..
5/10/202312:00GLOBECrossject : Information relative au nombre total de droits..
4/28/202312:27GLOBECrossject - Mise à disposition du rapport financier annuel..
4/28/202312:16GLOBECrossject - Rapport financier annuel 2022

Your Recent History

Delayed Upgrade Clock